Matthias Löhr is currently the president of UEG, previously secretary general of EPC and program director of Pancreas 2000. He is working with the pancreas for many decades. Löhr earned his MD from the University of Hamburg in Germany with MD thesis in pancreatic pathology with Günter Klöppel. After residency in pathology, postdoc at Scripps, La Jolla, CA. 1989-93 residency in Internal Medicine, Univ. of Erlangen, then Univ. of Rostock where he obtained his PhD on the molecular biology of the connective tissue in pancreatic diseases. 2000-07 Professor of Molecular Gastroenterology at Univ. of Heidelberg and head of a division at German Cancer Research Center (DKFZ). Since 2007, professor of Gastroenterology & Hepatology at Karolinska Institutet. Löhr led UEG guidelines for chronic pancreatitis (HaPanEU) and IgG4-related diseases. PI of early-phase clinical trials in pancreatic cancer. EU projects MolDiaPaCa, EPC-TM-Net, CanDo, PRECODE (active), PancAIM (active), PANCAID (active), GUIDE.MRD (active). Head of the Pancreas team at Karolinska and the HPB tumor network at CancerResearchKI where he is also in the steering committee. He received the life time achievement award of EPC in 2023. Current areas of interest are autoimmune pancreatitis, IPMN, familiar pancreatic cancer/IAR, early pancreatic cancer, and liquid biopsy.